O
60.61
1.92 (3.27%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Oruka Therapeutics, Inc. | Bearish | Bullish |
AIStockmoo Score
-1.6
| Analyst Consensus | -2.0 |
| Insider Activity | -5.0 |
| Price Volatility | -0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -1.60 |
|
Oruka Therapeutics Inc is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. It is to offer patients suffering from chronic skin diseases like plaque psoriasis. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 3.82% |
| % Held by Institutions | 86.62% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| AGARWAL ARJUN | - | 58.34 | -10,290 | -600,319 |
| DAMBKOWSKI CARL | - | 58.69 | -105,000 | -6,162,450 |
| GONCALVES JOANA | - | 61.93 | -7,000 | -433,510 |
| Aggregate Net Quantity | -122,290 | |||
| Aggregate Net Value ($) | -7,196,279 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 59.65 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| DAMBKOWSKI CARL | Director | 21 May 2026 | Automatic sell (-) | 105,000 | 58.69 | 6,162,450 |
| DAMBKOWSKI CARL | Director | 21 May 2026 | Option execute | 62,260 | - | - |
| AGARWAL ARJUN | Officer | 18 May 2026 | Automatic sell (-) | 10,290 | 58.34 | 600,319 |
| AGARWAL ARJUN | Officer | 18 May 2026 | Option execute | 7,833 | - | - |
| GONCALVES JOANA | Officer | 15 May 2026 | Automatic sell (-) | 7,000 | 61.93 | 433,510 |
| GONCALVES JOANA | Officer | 15 May 2026 | Option execute | 7,000 | - | - |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 29 Aug 2024 | - | 28 Aug 2024 | 1.613 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 1.61 | 1 | 8.32 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |